(Q41653923)

6 October 2017

1 reference

title

Primary prevention of sudden cardiac death in heart failure: will the solution be shocking? (English)

1 reference

6 October 2017

0 references

Uretsky BF

1

1 reference

6 October 2017

Sheahan RG

series ordinal

2

1 reference

6 October 2017

language of work or name

English

0 references

publication date

1 December 1997

1 reference

Journal of the American College of Cardiology

6 October 2017

published in

1 reference

6 October 2017

volume

30

1 reference

6 October 2017

issue

7

1 reference

6 October 2017

page(s)

1589-1597

1 reference

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

6 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

Predictors of total mortality and sudden death in mild to moderate heart failure. Captopril-Digoxin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

Prognosis in severe heart failure: relation to hemodynamic measurements and ventricular ectopic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

Arrhythmias and mortality in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST).

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

Nonischemic sudden tachyarrhythmic death in atherosclerotic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

Sudden coronary death. Frequency of active coronary lesions, inactive coronary lesions, and myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

Diverse mechanisms of unexpected cardiac arrest in advanced heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

Therapy of ventricular tachycardia in patients with nonischemic cardiomyopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

Survival of medically treated patients in the coronary artery surgery study (CASS) registry

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

Influence of implantable cardioverter-defibrillators on the long-term prognosis of survivors of out-of-hospital cardiac arrest

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

Mode of death in idiopathic dilated cardiomyopathy: a multivariate analysis of prognostic determinants.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

Risk factors for sudden death after acute myocardial infarction: two-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

Nonsustained ventricular tachycardia in severe heart failure. Independent marker of increased mortality due to sudden death. GESICA-GEMA Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

A new noninvasive index to predict sustained ventricular tachycardia and sudden death in the first year after myocardial infarction: based on signal-averaged electrocardiogram, radionuclide ejection fraction and Holter monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

Prediction of serious arrhythmic events after myocardial infarction: signal-averaged electrocardiogram, Holter monitoring and radionuclide ventriculography

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

Predicting arrhythmic events after acute myocardial infarction using the signal-averaged electrocardiogram

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

Comparison of frequency of late potentials in idiopathic dilated cardiomyopathy and ischemic cardiomyopathy with advanced congestive heart failure and their usefulness in predicting sudden death

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

Usefulness of signal-averaged electrocardiogram in idiopathic dilated cardiomyopathy for identifying patients with ventricular arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

Significance of aborted cardiac arrest and sustained ventricular tachycardia in patients referred for treatment therapy of advanced heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

Usefulness of programmed stimulation in idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

Electrophysiological testing and nonsustained ventricular tachycardia. Use and limitations in patients with coronary artery disease and impaired ventricular function

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

Electrophysiologic testing in the management of survivors of out-of-hospital cardiac arrest

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

The Effect of the Angiotensin-Converting–Enzyme Inhibitor Zofenopril on Mortality and Morbidity after Anterior Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

The effect of digoxin on mortality and morbidity in patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

Discontinuation of chronic diuretic therapy in stable congestive heart failure secondary to coronary artery disease or to idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

Effects of beta blockers on ventricular dysfunction after myocardial infarction: tolerability and survival effects

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II--DAVIT II)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

The effect of diltiazem on mortality and reinfarction after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

Effect of amiodarone on mortality after myocardial infarction: a double-blind, placebo-controlled, pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

Comparison of the effects of amiodarone versus metoprolol on the frequency of ventricular arrhythmias and on mortality after acute myocardial infarction. SSSD Investigators. Spanish Study on Sudden Death

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

Dead is dead--artificial definitions are no substitute

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

Mortality benefits and the implantable cardioverter-defibrillator

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

Prospective trials of implantable cardioverter defibrillators versus drugs: are they addressing the right question?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

Automatic implantable cardioverter defibrillators and survival of patients with left ventricular dysfunction and malignant ventricular arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

Long-term outcome of survivors of cardiac arrest whose therapy is guided by electrophysiologic testing

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

Long-Term Follow-Up of Patients with Nonischemic Dilated Cardiomyopathy and Ventricular Tachyarrhythmias Treated with Implantable Cardioverter Defibrillators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

Survival after implantation of the cardioverter defibrillator

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

Implantable cardioverter-defibrillator therapy in survivors of out-of-hospital sudden cardiac death without inducible arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

Influence of the Implantable Cardioverter/Defibrillator on Sudden Death and Total Mortality in Patients Evaluated for Cardiac Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

Results of the international study of the implantable pacemaker cardioverter-defibrillator. A comparison of epicardial and endocardial lead systems. The Pacemaker-Cardioverter-Defibrillator Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

Cost-Effectiveness of Implantable Cardioverter Defibrillators Relative to Amiodarone for Prevention of Sudden Cardiac Death

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

Prospective studies assessing prophylactic therapy in high risk patients: the German Dilated CardioMyopathy Study (GDCMS)--study design

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

Canadian Implantable Defibrillator Study (CIDS): study design and organization. CIDS Co-Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900361-6

7 January 2021

10.1016/S0735-1097(97)00361-6

Identifiers

DOI

1 reference

6 October 2017

1 reference